Skip to main content
Midas Edge

Guardant Health Inc

For the period ended Jun 30, 2024. Filed Aug 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 7, 2024

GH$155.35-2.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (unaudited)

(in thousands, except share data)

Three Months Ended June 30, 2024
Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’ Equity (Deficit)
Shares · Amount
Balance as of April 1, 2024121,787,297$1$2,329,930$(4,799)$(2,256,847)$68,285
Issuance of common stock upon exercise of stock options540,561—2,364——2,364
Vesting of restricted stock units269,896—————
Common stock issued under employee stock purchase plan371,826—7,212——7,212
Taxes paid related to net share settlement of restricted stock units——(3,240)——(3,240)
Stock-based compensation——27,235——27,235
Other comprehensive loss———(841)—(841)
Net loss————(102,628)(102,628)
Balance as of June 30, 2024122,969,580$1$2,363,501$(5,640)$(2,359,475)$(1,613)
Three Months Ended June 30, 2023
Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive (Loss) Income · Accumulated Deficit · Total Stockholders’ (Deficit) Equity
Shares · Amount
Balance as of April 1, 2023102,708,305$1$1,763,544$(12,150)$(1,795,946)$(44,551)
Issuance of common stock in public offering, net of offering costs of $21,13114,375,000—381,369——381,369
Issuance of common stock upon exercise of stock options10,830—63——63
Vesting of restricted stock units269,218—————
Common stock issued under employee stock purchase plan298,781—6,697——6,697
Taxes paid related to net share settlement of restricted stock units——(4,116)——(4,116)
Stock-based compensation——22,354——22,354
Other comprehensive income———3,681—3,681
Net loss————(72,771)(72,771)
Balance as of June 30, 2023117,662,134$1$2,169,911$(8,469)$(1,868,717)$292,726
Six Months Ended June 30, 2024
Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’ Equity (Deficit)
Shares · Amount
Balance as of January 1, 2024121,629,861$1$2,304,220$(3,675)$(2,141,862)$158,684
Issuance of common stock upon exercise of stock options577,352—2,577——2,577
Vesting of restricted stock units390,541—————
Common stock issued under employee stock purchase plan371,826—7,212——7,212
Taxes paid related to net share settlement of restricted stock units——(4,784)——(4,784)
Stock-based compensation——54,276——54,276
Other comprehensive loss———(1,965)—(1,965)
Net loss————(217,613)(217,613)
Balance as of June 30, 2024122,969,580$1$2,363,501$(5,640)$(2,359,475)$(1,613)
Six Months Ended June 30, 2023
Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive (Loss) Income · Accumulated Deficit · Total Stockholders’ Equity
Shares · Amount
Balance as of January 1, 2023102,619,383$1$1,742,114$(19,522)$(1,662,413)$60,180
Issuance of common stock in public offering, net of offering costs of $21,13114,375,000—381,369——381,369
Issuance of common stock upon exercise of stock options31,879—220——220
Vesting of restricted stock units337,091—————
Common stock issued under employee stock purchase plan298,781—6,697——6,697
Taxes paid related to net share settlement of restricted stock units——(5,109)——(5,109)
Stock-based compensation——44,620——44,620
Other comprehensive income———11,053—11,053
Net loss————(206,304)(206,304)
Balance as of June 30, 2023117,662,134$1$2,169,911$(8,469)$(1,868,717)$292,726
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.